Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alpha Healthcare Acquisition Corp was a healthcare-focused special purpose acquisition company (SPAC) formed to acquire or merge with one or more businesses in the healthcare sector. In August 2021, it completed its business combination with Humacyte, a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissues and organs. After the merger, the combined entity operates as Humacyte[2][3][4][10].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alpha Healthcare Acquisition Corp.